Marpai, Inc. (MRAI) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US5713542083
Marpai, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 18.10 m USD |
| Gross profit | 4.78 m USD |
| Operating income | -13.55 m USD |
| EBIT | -13.33 m USD |
| Net income | -16.56 m USD |
| Diluted EPS – continuing operations | -0.95 USD |
Full history since 2019, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Marpai, Inc.
Marpai, Inc., together with its subsidiaries, operates as a technology-driven healthcare payer company in the United States. The company provides third-party administrator and value-oriented health plan services to employers that directly pay for employee health benefits. It also offers in-house ancillary services that include clinical care management, a nurse-led guide for at-risk members across the care continuum; repricing insights, which are out-of-network claims; Marpai PACCS, a pharmacy advocacy cost containment solution that is a member-driven pharmacy savings program; and MarpaiRx, a national pharmacy benefit management program. In addition, the company provides health plan administration services, third-party vendor services, and complementary services, such as case management, actuarial, and bill review services. It serves the self-insured employer market through healthcare benefits brokers and consultants. Marpai, Inc. was incorporated in 2021 and is based in Tampa, Florida.
More stocks
- LumenRadio AB (LUMEN.ST)
- Rubicon Technology Inc (RBCN)
- OSE Pharma SA (OSE.PA)
- Ildong Holdings Co Ltd (000230.KS)
- Empresas la Polar SA (ABC.SN)
- XIIlab Co. Ltd. (189330.KQ)
- Sibek AB (publ) (SIBEK.ST)
- Mospec Semiconductor Corp (2434.TW)
- ONCOLYTICS BIOTECH INC (ONCY)
- Charlotte's Web Holdings, Inc. (CWBHF)
- RenovoRx, Inc. (RNXT)
- Berkah Prima Perkasa Tbk PT (BLUE.JK)
Not investment advice. All data without warranty, price as of 16.11.2026. Details in the risk notice.